Caption Management, LLC Cyma Bay Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$12.63 - $24.47 $3.84 Million - $7.43 Million	303,800 Added 56.67%	839,900 $19.8 Million
Q3 2023 Nov 14, 2023	BUY	$10.86 - $17.62 $5.82 Million - $9.45 Million	536,100 New	536,100 $7.99 Million
Q1 2023 May 15, 2023	BUY	$5.88 - $9.59 $147,000 - $239,750	25,000 Added 26.32%	120,000 $1.05 Million
Q4 2022 Feb 14, 2023	BUY	$3.22 - $6.27 $144,900 - $282,150	45,000 Added 90.0%	95,000 $595,000
Q3 2022 Nov 14, 2022	SELL	$2.77 - $4.25 $13,850 - $21,250	-5,000 Reduced 9.09%	50,000 $174,000
Q1 2022 May 13, 2022	BUY	$2.77 - $3.64 $152,350 - $200,200	55,000 New	55,000 $172,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.